Elicio Therapeutics, Inc.
Pharmaceutical Preparations · Boston, MA, United States
- PrincipalsPeter DeMuthChief Scientific OfficerRobert ConnellyCEO, President and Directorand 2 more
- CompanyElicio Therapeutics, Inc.Boston, MA, United States
- Phone line+1 (857) 209-0050General business
Elicio Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ELTX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 4
Chief executive
Robert ConnellyCEO, President and Director
Everyone else on file (3)
Peter DeMuthChief Scientific Officer
Christopher HaqqOfficer (see SEC filing)
Preetam ShahOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Robert Connelly — CEO, President and Director
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christopher Haqq — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Preetam Shah — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Peter DeMuth — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIITeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityPl. VIISilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPl. VIIEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityPl. VIIXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityPl. VIIMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPl. VIIAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityPl. VIIJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capability